Technical Analysis for LIXT - Lixte Biotech Hldgs

Grade Last Price % Change Price Change
grade B 1.17 9.35% 0.1000
LIXT closed up 9.35 percent on Wednesday, September 18, 2019, on 16 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical LIXT trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Wide Bands Range Expansion 0.00%
Fell Below 20 DMA Bearish 9.35%
Hammer Candlestick Bullish 9.35%
Narrow Range Bar Range Contraction 9.35%
Doji - Bullish? Reversal 9.35%
Wide Bands Range Expansion 9.35%
Gapped Down Weakness 9.35%
MACD Bearish Signal Line Cross Bearish -0.85%
Narrow Range Bar Range Contraction -0.85%

Older signals for LIXT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Lixte Biotechnology Holdings, Inc., including its subsidiary, Lixte Biotechnology, Inc., is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs compounds to attack those targets. The Company's primary focus is developing new treatments for human cancers. The Company designs drugs for which there are existing data suggesting that they may affect the altered pathways of the cancer cell and may be given safely to humans. This approach has led to the development of over two classes of drugs for the treatment of cancer, consisting of protein phosphatase inhibitors (PTase-i), designated by the Company as the LB-100 series of compounds, and histone deacetylase inhibitors (HDACi), designated by the Company as the LB-200 series of compounds. Compounds of both types also have use in the prevention and treatment of neurodegenerative diseases.
Branches Of Biology Cancer Health Sciences Drug Discovery Treatment Of Cancer Pharmaceutical Sciences Antineoplastic Drugs Neurodegenerative Diseases Histone Deacetylase
Is LIXT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 1.84
52 Week Low 0.125
Average Volume 3,087
200-Day Moving Average 0.92
50-Day Moving Average 1.0453
20-Day Moving Average 1.1551
10-Day Moving Average 1.2348
Average True Range 0.0985
ADX 16.12
+DI 33.7055
-DI 29.1307
Chandelier Exit (Long, 3 ATRs ) 1.1045
Chandelier Exit (Short, 3 ATRs ) 1.3055
Upper Bollinger Band 1.3698
Lower Bollinger Band 0.9404
Percent B (%b) 0.53
BandWidth 37.174271
MACD Line 0.0408
MACD Signal Line 0.0544
MACD Histogram -0.0136
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.3200
Resistance 3 (R3) 1.3033 1.2367 1.2950
Resistance 2 (R2) 1.2367 1.1985 1.2450 1.2867
Resistance 1 (R1) 1.2033 1.1749 1.2200 1.2200 1.2783
Pivot Point 1.1367 1.1367 1.1450 1.1450 1.1367
Support 1 (S1) 1.1033 1.0985 1.1200 1.1200 1.0617
Support 2 (S2) 1.0367 1.0749 1.0450 1.0533
Support 3 (S3) 1.0033 1.0367 1.0450
Support 4 (S4) 1.0200